The results of the longitudinal arm of our study highlight the modulation of systemic and TB-specific responses during ART-mediated virological suppression and the accompanying CD4 count rebound, albeit with a persistently higher risk of active TB infection compared to HIV-seronegative settings [47,48]. This evidence concerns the gene CD4 and tuberculosis.